Andreas Hallqvist
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Belzutifan for Advanced Pheochromocytoma or Paraganglioma.
Journal: The New England journal of medicine
Published: October 22, 2025
Brain metastasis in stage IV lung adenocarcinoma is frequently missed by symptom-based screening.
Journal: Discover oncology
Published: June 11, 2025
Coordinated humoral and cellular immune responses to COVID-19 vaccination in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 25, 2025
Monotherapy With Immune Checkpoint Blockade Improves Survival Outcomes in KRAS-Mutant but Not KRAS Wild-Type Metastatic Lung Adenocarcinoma: Validation From an Extended Swedish Cohort.
Journal: JTO clinical and research reports
Published: April 09, 2025
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: March 17, 2025
Distinct metastatic organotropism shapes prognosis in lung adenocarcinoma with brain metastasis.
Journal: Frontiers in oncology
Published: January 31, 2025
Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 22, 2024
177Lu-DOTATATE in Combination with PARP Inhibitor Olaparib Is Feasible in Patients with Somatostatin-Positive Tumors: Results from the LuPARP Phase I Trial.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 02, 2024
A semi-automated workflow for cohort-wise preparation of radiotherapy data for dose-response modeling, including autosegmentation of organs at risk.
Journal: Journal of applied clinical medical physics
Published: September 24, 2024
Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 05, 2024
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials.
Journal: Radiation oncology (London, England)
Published: July 01, 2024
Ageing promotes metastasis via activation of the integrated stress response.
Journal: Nature
Published: June 20, 2024
Last Updated: 09/26/2026